Kim Kelderman

Kim Kelderman

CEO · BIO-TECHNE Corp

Rank #15,080 SEC EDGAR (United States) ↗ Files from United States

Details

Officer and board memberPharmaceuticals & BiotechnologyTECHSEC CIK 0001739054

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$3.5M
1-day change
▼ 0.03%
Positions on file
1
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 53 weekly points

What the 1 currently disclosed position would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-09-05$2.1M – $3.5M2026-09-04

Insider activity Jul 31, 2024 – Nov 3, 2025

Kim Kelderman is recorded in filings to the U.S. SEC via EDGAR as officer and board member, and reported 14 transactions between Jul 31, 2024 and Nov 3, 2025. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
None
0 purchases on file
Open-market sales (code S)
$1.03M
2 sales on file priced rows only
All reported transactions
14
every code, including awards and exercises
Pattern
Bought and sold in similar amounts
last 12 months of the window

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 25 most recent rows are grouped into 24 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. CONMED Corp CNMD M Option exercise or conversionnot a buy/sell decisionreported at zero 500 shares $0 at $0.00 SEC filing ↗
  2. BIO-TECHNE Corp TECH F Shares withheld for taxesnot a buy/sell decision 10,821 shares $783.4K at $72.40 SEC filing ↗
  3. BIO-TECHNE Corp TECH M Option exercise or conversionnot a buy/sell decisionreported at zero 21,470 shares $0 at $0.00 SEC filing ↗
  4. BIO-TECHNE Corp TECH F Shares withheld for taxesnot a buy/sell decision 28,686 shares $2.07M at $72.07 SEC filing ↗
  5. BIO-TECHNE Corp TECH M Option exercise or conversionnot a buy/sell decision 35,000 shares $1.67M at $47.60 SEC filing ↗
  6. BIO-TECHNE Corp TECH F Shares withheld for taxesnot a buy/sell decision 23,951 shares $1.36M at $56.68 SEC filing ↗
  7. BIO-TECHNE Corp TECH M Option exercise or conversionnot a buy/sell decision 26,692 shares $1.27M at $47.60 SEC filing ↗
  8. BIO-TECHNE Corp TECH F Shares withheld for taxesnot a buy/sell decision 1,363 shares $79.8K at $58.58 SEC filing ↗
  9. BIO-TECHNE Corp TECH M Option exercise or conversionnot a buy/sell decisionreported at zero 11,344 shares $0 at $0.00 SEC filing ↗
  10. BIO-TECHNE Corp TECH F Shares withheld for taxesnot a buy/sell decision 32,088 shares $1.88M at $58.66 SEC filing ↗
  11. BIO-TECHNE Corp TECH M Option exercise or conversionnot a buy/sell decisionreported at zero 36,500 shares $0 at $0.00 SEC filing ↗
  12. BIO-TECHNE Corp TECH F Shares withheld for taxesnot a buy/sell decision 2,303 shares $144.1K at $62.57 SEC filing ↗
  13. BIO-TECHNE Corp TECH M Option exercise or conversionnot a buy/sell decisionreported at zero 8,543 shares $0 at $0.00 SEC filing ↗
  14. BIO-TECHNE Corp TECH F Shares withheld for taxesnot a buy/sell decision 4,305 shares $230.7K at $53.60 SEC filing ↗
  15. BIO-TECHNE Corp TECH M Option exercise or conversionnot a buy/sell decision 48,176 shares $2.14M at $44.33 SEC filing ↗
  16. BIO-TECHNE Corp TECH F Shares withheld for taxesnot a buy/sell decision 43,649 shares $2.32M at $53.12 SEC filing ↗
  17. BIO-TECHNE Corp TECH M Option exercise or conversionnot a buy/sell decision 36,132 shares $1.60M at $44.33 SEC filing ↗
  18. BIO-TECHNE Corp TECH F Shares withheld for taxesnot a buy/sell decision 32,933 shares $1.69M at $51.42 SEC filing ↗
  19. BIO-TECHNE Corp TECH S Open-market sale × 2 13,392 shares $1.03M
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    1,661 $77.95 $129.5K SEC filing ↗
    11,731 $77.19 $905.5K SEC filing ↗
  20. BIO-TECHNE Corp TECH M Option exercise or conversionnot a buy/sell decision 13,392 shares $504.9K at $37.70 SEC filing ↗
  21. BIO-TECHNE Corp TECH F Shares withheld for taxesnot a buy/sell decision 2,430 shares $183.0K at $75.31 SEC filing ↗
  22. BIO-TECHNE Corp TECH M Option exercise or conversionnot a buy/sell decision 1,492 shares $99.9K at $66.97 SEC filing ↗
  23. BIO-TECHNE Corp TECH M Option exercise or conversionnot a buy/sell decision 14,000 shares $527.8K at $37.70 SEC filing ↗
  24. BIO-TECHNE Corp TECH F Shares withheld for taxesnot a buy/sell decision 9,479 shares $777.0K at $81.97 SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
BIO-TECHNE Corp TECH Common Stock 48,665 $72.43 $3.5M 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where Kim Kelderman reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Portrait photograph: BIO-TECHNE Corp (company-published photograph). Original file page on investors.bio-techne.com ↗

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.